title: Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.
authors.affiliation: Bangladesh Institute of Family Medicine and Research at the University of Science and Technology of Chittagong in Dhaka, Bangladesh.
authors.forename: Gauranga Chandra
authors.initials: GC
authors.lastname: Dhar
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring; D005194:Family Practice / Q000592:standards; D006442:Glycated Hemoglobin / Q000187:drug effects*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents
references.citation: N Engl J Med. 1993 Sep 30;329(14):977-86
references.pmid: 8366922
references.citation: Lancet. 1998 Sep 12;352(9131):837-53
references.pmid: 9742976
references.citation: N Engl J Med. 2008 Jun 12;358(24):2545-59
references.pmid: 18539917
references.citation: N Engl J Med. 2009 Jan 8;360(2):129-39
references.pmid: 19092145
references.citation: N Engl J Med. 2008 Jun 12;358(24):2537-9
references.pmid: 18539915
references.citation: N Engl J Med. 2008 Jun 12;358(24):2560-72
references.pmid: 18539916